Comment RNS 17.4.154 Dec 2016 18:36
Quote:
"Professor Keith Muir, SINAPSE Professor of Clinical Imaging, Division of Clinical Neurosciences at the University of Glasgow, and Principal Investigator of the PISCES study, said:
"We continue to be both pleased and encouraged by the data from the PISCES study. The long term follow-up data continue to demonstrate the safety and tolerability of the CTX treatment. The evidence of functional improvement warrant further investigation and, in this regard, we are delighted to be a principal participating centre in the ongoing Phase II efficacy study with CTX."